Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corvus Pharmaceuticals

4.38
+0.25006.05%
Post-market: 4.390.0100+0.23%19:33 EST
Volume:665.84K
Turnover:2.87M
Market Cap:281.45M
PE:-4.33
High:4.47
Open:4.05
Low:4.01
Close:4.13
Loading ...

Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer

THOMSON REUTERS
·
10 Nov 2024

Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer

GlobeNewswire
·
10 Nov 2024

Corvus Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024

GlobeNewswire
·
06 Nov 2024

Corvus Pharmaceuticals options imply 12.0% move in share price post-earnings

TIPRANKS
·
06 Nov 2024

Corvus Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
02 Nov 2024

Corvus Pharmaceuticals Shares Rise After Mizuho Upgrade

MT Newswires Live
·
23 Oct 2024

Corvus Pharmaceuticals Shares up 3.6% After Mizuho Raises to Outperform From Neutral

THOMSON REUTERS
·
22 Oct 2024

BUZZ-Corvus Pharmaceuticals jumps after Mizuho upgrades to 'outperform'

Reuters
·
22 Oct 2024

Mizuho Upgrades Corvus Pharmaceuticals to Outperform From Neutral, Adjusts Price Target to $12 From $3.50

MT Newswires Live
·
22 Oct 2024

Corvus Pharmaceuticals upgraded to Outperform from Neutral at Mizuho

TIPRANKS
·
22 Oct 2024

Corvus Pharmaceuticals Inc : Mizuho Raises to Outperform From Neutral

THOMSON REUTERS
·
22 Oct 2024

Insiders of Corvus Pharmaceuticals Getting Good Value On Their US$1.03m Investment

Simply Wall St.
·
17 Oct 2024

Corvus Stock Up on Initiation of Phase III Lymphoma Study on Lead Drug

Zacks
·
11 Sep 2024

BRIEF-Corvus Pharmaceuticals Says Trial To Enroll Patients At 40 Sites In US, Canada, Australia, South Korea

Reuters
·
10 Sep 2024

Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

THOMSON REUTERS
·
10 Sep 2024